拓斯達(300607.SZ):公司機器人客户主要分佈在3C行業
格隆匯10月25日丨拓斯達(300607.SZ)投資者關係活動記錄表顯示,公司機器人客户主要分佈在3C行業。今年自產多關節工業機器人大幅增長的原因主要是公司繼續深耕3C行業,在大客户開拓上取得明顯成效。如除了果鏈的伯恩、富士康等老客户之外,新開拓非果鏈的華勤、龍旗、聞泰等客户,公司結合機器人核心底層技術及本體技術的積累和對客户工藝的深度理解,為客户提供精度高、穩定性好、耐用性強、性價比高的“機器人+”工作站。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.